Specialty Generics
Total Trials
15
As Lead Sponsor
10
As Collaborator
5
Total Enrollment
3,963
NCT00063687
Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure
Phase: Phase 2/3
Role: Lead Sponsor
Start: Mar 31, 2003
Completion: Jun 30, 2005
NCT00468767
Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
Phase: Phase 3
Start: Aug 31, 2003
Completion: Nov 30, 2004
NCT00476112
A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Completion: Sep 30, 2004
NCT00115791
Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
Role: Collaborator
Start: Jun 30, 2004
NCT00125320
Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery
Completion: Feb 28, 2007
NCT00281554
Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation
Start: Oct 31, 2005
Completion: Jan 31, 2007
NCT00267930
Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence
Phase: Phase 2
Start: Dec 31, 2005
Completion: Aug 31, 2006
NCT00526136
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Start: Mar 31, 2007
Completion: Jul 31, 2008
NCT00668759
A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
Start: Apr 30, 2008
Completion: Nov 30, 2009
NCT00989001
A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045)
Start: Oct 31, 2009
Completion: Nov 30, 2010
NCT01174160
A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)
Start: Aug 31, 2010
Completion: Oct 31, 2012
NCT01627106
A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)
Phase: Phase 4
Start: Sep 30, 2012
Completion: Mar 31, 2016
NCT02955004
Electrical Cardioversion of Recent Onset Atrial Fibrillation - Silent Thromboembolic Events, Reverse Atrial Remodeling
Phase: N/A
Start: Feb 28, 2015
Completion: Dec 31, 2017
NCT04170309
Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases
Start: Mar 30, 2020
Completion: Jun 9, 2023
NCT05117398
Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
Start: Jun 23, 2023
Completion: Sep 23, 2026
Loading map...